OCULAR PRESSURE-REDUCING AGENT CONTAINING COMPOUND WHICH HAS HISTONE DEACETYLASE INHIBITORY ACTION AS ACTIVE INGREDIENT

PROBLEM TO BE SOLVED: To provide a compound having a histone deacetylase (HDAC) inhibitory action and further having a new pharmacological action. SOLUTION: The compound having an HDAC inhibitory action has an excellent ability of changing the cytomorphology of trabecular cells and/or an excellent o...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: FUJIKAWA JUNKO, YONEDA SHINJI, SHIMAZAKI ATSUSHI, FUJISAWA YUKIFUMI, TAJIMA HISATSUGU, KIRIHARA TOMOKO, WATANABE KATSUHIKO
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:PROBLEM TO BE SOLVED: To provide a compound having a histone deacetylase (HDAC) inhibitory action and further having a new pharmacological action. SOLUTION: The compound having an HDAC inhibitory action has an excellent ability of changing the cytomorphology of trabecular cells and/or an excellent ocular hypotensive activity, and is accordingly useful as a prophylactic and/or therapeutic agent for a disease associated with aqueous humor circulation and/or ocular tension, particularly the prophylactic and/or therapeutic agent for glaucoma and ocular hypertension. COPYRIGHT: (C)2009,JPO&INPIT